Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
The latest announcement is out from Mayne Pharma Group ( (AU:MYX) ).
Mayne Pharma Group has announced that Mitsubishi UFJ Financial Group, through its subsidiary First Sentier Investors Holdings Pty Limited, has acquired a substantial holding in the company. This acquisition grants Mitsubishi UFJ Financial Group significant voting power and influence over Mayne Pharma’s operations, potentially impacting its strategic direction and market positioning.
The most recent analyst rating on (AU:MYX) stock is a Buy with a A$6.69 price target. To see the full list of analyst forecasts on Mayne Pharma Group stock, see the AU:MYX Stock Forecast page.
More about Mayne Pharma Group
Average Trading Volume: 976,422
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$364M
See more insights into MYX stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue